文献速递头颈外科

老年头颈癌患者的新辅助化疗

Neoadjuvant chemotherapy in geriatric head and neck cancers.
PubMed 文献 · Head Neck · 2017-03-01

本研究纳入49例接受新辅助化疗的局部晚期老年头颈癌患者,46例完成新辅助化疗(93.9%)。以器官保留为目的者(n=15)局部治疗依从性为73.3%,中位总生存期为49.9个月(95%CI 22.0-77.8个月);因技术上不可切除而化疗者局部治疗依从性为82.06%,中位总生存期为9.0个月(95%CI 5.9-12.1个月)。作者认为个体化新辅助化疗方案在老年患者中治疗依从性高,器官保留者的中位总生存期与年轻患者相似。

要点

  • 49例老年局部晚期头颈癌患者中46例完成新辅助化疗,完成率93.9%。
  • 器官保留组(n=15)局部治疗依从性73.3%,中位总生存期49.9个月(95%CI 22.0-77.8个月)。
  • 不可切除组局部治疗依从性82.06%,中位总生存期9.0个月(95%CI 5.9-12.1个月)。

核心结论

  • 个体化新辅助化疗方案在老年头颈癌患者中治疗依从性高,以器官保留为目的的老年患者中位总生存期与年轻患者相似。

研究设计与样本

  • 本研究为单臂分析,纳入49例接受新辅助化疗后行根治性治疗的局部晚期老年头颈癌患者,估计总生存期和无进展生存期。

主要发现

  • 49例中46例完成新辅助化疗,完成率为93.9%。
  • 以器官保留为目的接受新辅助化疗者(n=15)局部治疗依从性为73.3%,中位总生存期为49.9个月(95%CI 22.0-77.8个月)。
  • 因技术上不可切除而接受新辅助化疗者局部治疗依从性为82.06%,中位总生存期为9.0个月(95%CI 5.9-12.1个月)。

临床怎么用

  • 原文结论认为个体化新辅助化疗方案在老年患者中治疗依从性高,器官保留者的中位总生存期与年轻患者相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to present our findings on the treatment completion rates and outcomes in geriatric patients with head and neck cancer treated with neoadjuvant chemotherapy followed by definitive therapy. METHODS: Geriatric patients with locally advanced head and neck cancer who received neoadjuvant chemotherapy were selected for this analysis. Overall survival (OS) and progression-free survival (PFS) were estimated. RESULTS: Forty-six of 49 patients completed neoadjuvant chemotherapy (93.9%). The compliance to local treatment was 73.3% and the median OS was 49.9 months (95% confidence interval [CI] = 22.0-77.8 months) in patients who received neoadjuvant chemotherapy for organ preservation (n = 15). In patients receiving neoadjuvant chemotherapy for technically unresectable disease, the corresponding figures were 82.06% and 9.0 months (95% CI = 5.9-12.1 months), respectively. CONCLUSION: Individualized neoadjuvant chemotherapy protocols in geriatric patients have high compliance rates to treatment and the median OS in geriatric patients treated for organ preservation is similar to that of young patients. © 2017 Wiley Periodicals, Inc. Head Neck 39: 886-892, 2017.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Patil VM, Noronha V, Joshi A, et al. Neoadjuvant chemotherapy in geriatric head and neck cancers. Head Neck. 2017. PMID: 28248432. doi:10.1002/hed.24694

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。